This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/507956-russia-india-sputnikv-vaccine/
The article has changed 4 times. There is an RSS feed of changes available.
| Version 2 | Version 3 |
|---|---|
| Russia strikes deal with India to produce 100 million doses of Sputnik V Covid-19 vaccine per year | |
| (about 2 months later) | |
| The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil. | The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil. |
| Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement. | Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement. |
| RDIF chief Kirill Dmitriev said the deal will “provide the people of India with an efficient solution in this challenging period of the pandemic.” He added that Sputnik V should become “an integral part of the national vaccine portfolio” of every country. | RDIF chief Kirill Dmitriev said the deal will “provide the people of India with an efficient solution in this challenging period of the pandemic.” He added that Sputnik V should become “an integral part of the national vaccine portfolio” of every country. |
| Director of international marketing at Hetero Labs Limited, B. Murali Krishna Reddy, hailed the collaboration as “another step towards our commitment in the battle against Covid-19.” | Director of international marketing at Hetero Labs Limited, B. Murali Krishna Reddy, hailed the collaboration as “another step towards our commitment in the battle against Covid-19.” |
| In August, Russia became the first country to register a vaccine for Covid-19. On Tuesday, Russian officials said Sputnik V’s efficacy rate was 91.4 percent a week after a second dose was administered to volunteers. | In August, Russia became the first country to register a vaccine for Covid-19. On Tuesday, Russian officials said Sputnik V’s efficacy rate was 91.4 percent a week after a second dose was administered to volunteers. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |